Starling Oncology (STLN)'s 30-day implied volatility (IV30) was 60.7% at the close on November 10, 2026, down from 76.1% the day before, against a 52-week range of 40.0% to 400.0%. Its 20-day historical volatility was 67.8%.
Data as of November 10, 2026.